MediWound

NASDAQ MDWD
$18.65 0.0000 0.0000%
Today share price
Israel
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 18 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

171.95M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

160.28M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

1.55
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

9.22M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

83.38 %

Upcoming events MediWound

All events
No upcoming events scheduled

Stock chart MediWound

Stock analysis MediWound

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-25.60 35.47
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
5.44 14.09
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-11.47 17.40
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.84 0.37
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-21.26 8.90

Price change MediWound per year

3.08$ 6.07$
Min Max

Summary analysis MediWound

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure MediWound

Revenue and net income MediWound

All parameters

Stock news MediWound

All news

MediWound Shares Climb on Positive Data for EscharEx

MediWound Shares Climb on Positive Data for EscharEx

MediWound Gets CHMP Positive Opinion for NexoBrid

MediWound Gets CHMP Positive Opinion for NexoBrid

MediWound, Vericel Get FDA Approval for NexoBrid Burn Treatment

MediWound, Vericel Get FDA Approval for NexoBrid Burn Treatment

MediWound Plans 1-for-7 Reverse Stock Split

MediWound Plans 1-for-7 Reverse Stock Split

MediWound Shares Slide Premarket After Stock Offerings >MDWD

MediWound Shares Slide Premarket After Stock Offerings >MDWD

MediWound Says Initial Data Positive in Skin Cancer Study of MW005

MediWound Says Initial Data Positive in Skin Cancer Study of MW005

MediWound Sees Positive Results From Phase 2 Trial of EscharEx

MediWound Sees Positive Results From Phase 2 Trial of EscharEx

MediWound Names Ofer Gonen to Succeed Sharon Malka as CEO >MDWD

MediWound Names Ofer Gonen to Succeed Sharon Malka as CEO >MDWD

MediWound Shares Up After EscharEx Study Met Primary Endpoint

MediWound Shares Up After EscharEx Study Met Primary Endpoint

MediWound Shares Drop 14% After Public Offering Prices

MediWound Shares Drop 14% After Public Offering Prices

About company MediWound

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MWPC005, a topically applied biological drug candidate that is in Phase I/II clinical trial for the treatment of non-melanoma skin cancers; and MWPC003 for connective tissue disorders. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.
Address:
42 Hayarkon Street, Yavne, Israel, 8122745
Company name: MediWound
Issuer ticker: MDWD
ISIN: IL0011316309
Country: Israel
Exchange: NASDAQ
Currency: $
IPO date: 2014-03-20
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.mediwound.com

On which stock exchange are MediWound (MDWD) stocks traded?

MediWound (MDWD) stocks are traded on NASDAQ.

What is the ticker of MediWound stocks (MDWD)?

The stock ticker of MediWound’s stocks or in other words, the code is MDWD. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does MediWound (MDWD) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, MediWound (MDWD) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are MediWound (MDWD) stocks traded?

MediWound (MDWD) stocks are traded on the NASDAQ exchange in dollars.

What is the price of MediWound (MDWD) stocks today?

The current price of MediWound stocks on 05.05.2024 is 18.65 dollars. per share.

What is the dynamics of MediWound (MDWD) stocks from the beginning of the year?

MediWound (MDWD) quotes have increased by 65.78% from the beginning of the year up to 18.65 dollars. per 1 stocks.

How much did MediWound (MDWD) stocks increase in мае 2024?

This month MediWound (MDWD) quotes have increased by -3.22% to 18.65 dollars. per share.

How much are MediWound (MDWD) stocks worth?

Today, on October, 05.05.2024 MediWound’s (MDWD) stocks cost 18.65 dollars..

What is the market capitalization of MediWound (MDWD)?

Capitalization is the market value of MediWound (MDWD) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 05.05.2024, the market capitalization of MediWound (MDWD) is estimated at about 171951564 dollars.